Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Perspective

Eating Disorders in the Time of the COVID-19 Pandemic: A Perspective

Author(s): Simonetta Marucci*, Guido Almerighi, Nadia Cerutti, Filomena Corbo, Roberta Zupo, Giulia De Iaco, Giuseppe Lisco, Vincenzo Triggiani and Giovanni De Pergola

Volume 23, Issue 2, 2023

Published on: 10 August, 2022

Page: [123 - 128] Pages: 6

DOI: 10.2174/1871530322666220422104009

Price: $65

Abstract

Background: Due to the COVID-19 pandemic, current epidemiological conditions may exacerbate the risk of new-onset, recurrence and relapse of eating disorders. This perspective aims to better analyse the phenomenon.

Results: Some data suggest that new-onset and recurrence/relapse of eating disorders are increasing due to the pandemic. Government restrictions, self-confinement, social isolation, restriction to healthcare facilities access, delayed access to diagnosis and cure, fear of contagion, distress and difficulties related to the telemedicine approach contribute to this burden. The Immune system dysfunction usually observed in undernourishment (e.g., anorexia nervosa) could delay the diagnosis of respiratory infections, including COVID-19, and predispose to possible bacterial superinfections. Conversely, patients with binge eating, obesity or metabolic syndrome are susceptible to high-grade systemic inflammation and poor prognosis once the infection has occurred.

Discussion: More detailed data combining research on eating disorders and COVID-19 are required despite some evidence. Many data show that telemedicine has beneficial aspects, but its impact on long-term mental health is still poorly understood. Short- and long-term consequences of COVID-19 in patients with eating disorders are unknown, but they will likely become more apparent over time.

Conclusion: Working on emotion regulating strategies in a post-pandemic world, when people have inadequate control over the background of negative emotions, could be a future treatment strategy. Long-term studies with a larger sample size are essential to assess the long-term consequences of the blockade on patients and their healthcare providers and identify useful strategies to improve clinical management.

Keywords: Sars-cov-2, COVID-19, pandemic, eating disorders, anorexia nervosa, obesity.

Next »
[1]
Smink, F.R.; van Hoeken, D.; Hoek, H.W. Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr. Psychiatry Rep., 2012, 14(4), 406-414.
[http://dx.doi.org/10.1007/s11920-012-0282-y] [PMID: 22644309]
[2]
Harris, E.C.; Barraclough, B. Excess mortality of mental disorder. Br. J. Psychiatry, 1998, 173(1), 11-53.
[http://dx.doi.org/10.1192/bjp.173.1.11] [PMID: 9850203]
[3]
Marucci, S.; Ragione, L.D.; De Iaco, G.; Mococci, T.; Vicini, M.; Guastamacchia, E.; Triggiani, V. Anorexia nervosa and comorbid psychopathology. Endocr. Metab. Immune Disord. Drug Targets, 2018, 18(4), 316-324.
[http://dx.doi.org/10.2174/1871530318666180213111637] [PMID: 29437020]
[4]
Fernandez-Aranda, F.; Pinheiro, A.P.; Tozzi, F.; Thornton, L.M.; Fichter, M.M.; Halmi, K.A.; Kaplan, A.S.; Klump, K.L.; Strober, M.; Woodside, D.B.; Crow, S.; Mitchell, J.; Rotondo, A.; Keel, P.; Plotnicov, K.H.; Berrettini, W.H.; Kaye, W.H.; Crawford, S.F.; Johnson, C.; Brandt, H.; La Via, M.; Bulik, C.M. Symptom profile of major depressive disorder in women with eating disorders. Aust. N. Z. J. Psychiatry, 2007, 41(1), 24-31.
[http://dx.doi.org/10.1080/00048670601057718] [PMID: 17464678]
[5]
Swinbourne, J.M.; Touyz, S.W. The co-morbidity of eating disorders and anxiety disorders: a review. Eur. Eat. Disord. Rev., 2007, 15(4), 253-274.
[http://dx.doi.org/10.1002/erv.784] [PMID: 17676696]
[6]
Halmi, K.A.; Sunday, S.R.; Klump, K.L.; Strober, M.; Leckman, J.F.; Fichter, M.; Kaplan, A.; Woodside, B.; Treasure, J.; Berrettini, W.H.; Al Shabboat, M.; Bulik, C.M.; Kaye, W.H. Obsessions and compulsions in anorexia nervosa subtypes. Int. J. Eat. Disord., 2003, 33(3), 308-319.
[http://dx.doi.org/10.1002/eat.10138] [PMID: 12655628]
[7]
Caglar-Nazali, H.P.; Corfield, F.; Cardi, V.; Ambwani, S.; Leppanen, J.; Olabintan, O.; Deriziotis, S.; Hadjimichalis, A.; Scognamiglio, P.; Eshkevari, E.; Micali, N.; Treasure, J. A systematic review and meta-analysis of ‘Systems for Social Processes’ in eating disorders. Neurosci. Biobehav. Rev., 2014, 42, 55-92.
[http://dx.doi.org/10.1016/j.neubiorev.2013.12.002] [PMID: 24333650]
[8]
Brooks, S.K.; Webster, R.K.; Smith, L.E.; Woodland, L.; Wessely, S.; Greenberg, N.; Rubin, G.J. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet, 2020, 395(10227), 912-920.
[http://dx.doi.org/10.1016/S0140-6736(20)30460-8] [PMID: 32112714]
[9]
Todisco, P.; Donini, L.M. Eating disorders and obesity (ED&O) in the COVID-19 storm. Eat. Weight Disord., 2021, 26(3), 747-750.
[http://dx.doi.org/10.1007/s40519-020-00938-z] [PMID: 32488728]
[10]
Touyz, S.; Lacey, H.; Hay, P. Eating disorders in the time of COVID-19. J. Eat. Disord., 2020, 8(1), 19.
[http://dx.doi.org/10.1186/s40337-020-00295-3] [PMID: 32337045]
[11]
Haddad, C.; Zakhour, M.; Bou Kheir, M.; Haddad, R.; Al Hachach, M.; Sacre, H.; Salameh, P. Association between eating behavior and quarantine/confinement stressors during the coronavirus disease 2019 outbreak. J. Eat. Disord., 2020, 8(1), 40.
[http://dx.doi.org/10.1186/s40337-020-00317-0] [PMID: 32879730]
[12]
Nutley, S.K.; Falise, M.A.; Henderson, R.; Apostolou, V.; Mathews, C.A.; Striley, C.W. Impact of the COVID-19 Pandemic on Disordered Eating Behavior: Qualitative Analysis of Social Media Posts. JMIR Ment. Health, 2021, 8(1)e26011
[13]
Phillipou, A.; Meyer, D.; Neill, E.; Tan, E.J.; Toh, W.L.; Van Rheenen, T.E.; Rossell, S.L. Eating and exercise behaviors in eating disorders and the general population during the COVID-19 pandemic in Australia: Initial results from the COLLATE project. Int. J. Eat. Disord., 2020, 53(7), 1158-1165.
[http://dx.doi.org/10.1002/eat.23317] [PMID: 32476163]
[14]
Rodgers, R.F.; Lombardo, C.; Cerolini, S.; Franko, D.L.; Omori, M.; Fuller-Tyszkiewicz, M.; Linardon, J.; Courtet, P.; Guillaume, S. The impact of the COVID-19 pandemic on eating disorder risk and symptoms. Int. J. Eat. Disord., 2020, 53(7), 1166-1170.
[http://dx.doi.org/10.1002/eat.23318] [PMID: 32476175]
[15]
Weissman, R.S.; Bauer, S.; Thomas, J.J. Access to evidence-based care for eating disorders during the COVID-19 crisis. Int. J. Eat. Disord., 2020, 53(5), 369-376.
[http://dx.doi.org/10.1002/eat.23279] [PMID: 32338400]
[16]
Clark Bryan, D.; Macdonald, P.; Ambwani, S.; Cardi, V.; Rowlands, K.; Willmott, D.; Treasure, J. Exploring the ways in which COVID-19 and lockdown has affected the lives of adult patients with anorexia nervosa and their carers. Eur. Eat. Disord. Rev., 2020, 28(6), 826-835.
[http://dx.doi.org/10.1002/erv.2762] [PMID: 32643844]
[17]
Schlegl, S.; Maier, J.; Meule, A.; Voderholzer, U. Eating disorders in times of the COVID-19 pandemic-Results from an online survey of patients with anorexia nervosa. Int. J. Eat. Disord., 2020, 53(11), 1791-1800.
[http://dx.doi.org/10.1002/eat.23374] [PMID: 32841413]
[18]
Pearl, R.L. Weight Stigma and the “Quarantine-15”. Obesity (Silver Spring), 2020, 28(7), 1180-1181.
[http://dx.doi.org/10.1002/oby.22850] [PMID: 32324954]
[19]
Khosravi, M. The challenges ahead for patients with feeding and eating disorders during the COVID-19 pandemic. J. Eat. Disord., 2020, 8(1), 43.
[http://dx.doi.org/10.1186/s40337-020-00322-3] [PMID: 32922783]
[20]
Colleluori, G.; Goria, I.; Zillanti, C.; Marucci, S.; Dalla Ragione, L. Eating disorders during COVID-19 pandemic: the experience of Italian healthcare providers. Eat. Weight Disord., 2021, 26(8), 2787-2793.
[http://dx.doi.org/10.1007/s40519-021-01116-5] [PMID: 33560511]
[21]
NIH US National Library of Medicine, Eating Habits of Adults During the Quarantine.Clinical trials 2020. Available from:, https://clinicaltrials.gov/ct2/show/NCT04339842 [Last accessed 25 Apr 2020].
[22]
Braden, A.; Musher-Eizenman, D.; Watford, T.; Emley, E. Eating when depressed, anxious, bored, or happy: Are emotional eating types associated with unique psychological and physical health correlates? Appetite, 2018, 125, 410-417.
[http://dx.doi.org/10.1016/j.appet.2018.02.022] [PMID: 29476800]
[23]
Machado, P.P.P.; Pinto-Bastos, A.; Ramos, R.; Rodrigues, T.F.; Louro, E.; Gonçalves, S.; Brandão, I.; Vaz, A. Impact of COVID-19 lockdown measures on a cohort of eating disorders patients. J. Eat. Disord., 2020, 8(1), 57.
[http://dx.doi.org/10.1186/s40337-020-00340-1] [PMID: 33292539]
[24]
Castellini, G.; Cassioli, E.; Rossi, E.; Innocenti, M.; Gironi, V.; Sanfilippo, G.; Felciai, F.; Monteleone, A.M.; Ricca, V. The impact of COVID-19 epidemic on eating disorders: A longitudinal observation of pre versus post psychopathological features in a sample of patients with eating disorders and a group of healthy controls. Int. J. Eat. Disord., 2020, 53(11), 1855-1862.
[http://dx.doi.org/10.1002/eat.23368] [PMID: 32856333]
[25]
Fiorillo, A.; Gorwood, P. The consequences of the COVID-19 pandemic on mental health and implications for clinical practice. Eur. Psychiatry, 2020, 63(1)e32
[http://dx.doi.org/10.1192/j.eurpsy.2020.35] [PMID: 32234102]
[26]
Fernández-Aranda, F.; Casas, M.; Claes, L.; Bryan, D.C.; Favaro, A.; Granero, R.; Gudiol, C.; Jiménez-Murcia, S.; Karwautz, A.; Le Grange, D.; Menchón, J.M.; Tchanturia, K.; Treasure, J. COVID-19 and implications for eating disorders. Eur. Eat. Disord. Rev., 2020, 28(3), 239-245.
[http://dx.doi.org/10.1002/erv.2738] [PMID: 32346977]
[27]
Termorshuizen, J.D.; Watson, H.J.; Thornton, L.M.; Borg, S.; Flatt, R.E.; MacDermod, C.M.; Harper, L.E.; van Furth, E.F.; Peat, C.M.; Bulik, C.M. Early impact of COVID-19 on individuals with self-reported eating disorders: A survey of ~1,000 individuals in the United States and the Netherlands. Int. J. Eat. Disord., 2020, 53(11), 1780-1790.
[http://dx.doi.org/10.1002/eat.23353] [PMID: 32720399]
[28]
Tuerk, P.W.; Keller, S.M.; Acierno, R. Treatment for anxiety and depression via clinical videoconferencing: evidence base and barriers to expanded access in practice. Focus Am. Psychiatr. Publ., 2018, 16(4), 363-369.
[http://dx.doi.org/10.1176/appi.focus.20180027] [PMID: 31975928]
[29]
Simpson, S.; Bell, L.; Knox, J.; Mitchell, D. Therapy via videoconferencing: a route to client empowerment? Clin. Psychol. Psychother., 2005, 12(2), 156-165.
[http://dx.doi.org/10.1002/cpp.436]
[30]
Simeunovic Ostojic, M.; Maas, J.; Bodde, N.M.G. COVID-19, anorexia nervosa and obese patients with an eating disorder - some considerations for practitioners and researchers. J. Eat. Disord., 2021, 9(1), 15.
[http://dx.doi.org/10.1186/s40337-021-00369-w] [PMID: 33472682]
[31]
Achamrah, N.; Déchelotte, P.; Coëffierabc, M. New therapeutic approaches to target gut-brain axis dysfunction during anorexia nervosa. Clin. Nutr. Exp., 2019, 28, 33-41.
[http://dx.doi.org/10.1016/j.yclnex.2019.01.006]
[32]
Roubalová, R.; Procházková, P.; Papežová, H.; Smitka, K.; Bilej, M.; Tlaskalová-Hogenová, H. Anorexia nervosa: Gut microbiota-immune-brain interactions. Clin. Nutr., 2020, 39(3), 676-684.
[http://dx.doi.org/10.1016/j.clnu.2019.03.023] [PMID: 30952533]
[33]
Hart, A.; Kamm, M.A. Review article: mechanisms of initiation and perpetuation of gut inflammation by stress. Aliment. Pharmacol. Ther., 2002, 16(12), 2017-2028.
[http://dx.doi.org/10.1046/j.1365-2036.2002.01359.x] [PMID: 12452934]
[34]
Dobner, J.; Kaser, S. Body mass index and the risk of infection - from underweight to obesity. Clin. Microbiol. Infect., 2018, 24(1), 24-28.
[http://dx.doi.org/10.1016/j.cmi.2017.02.013] [PMID: 28232162]
[35]
Brown, R.F.; Bartrop, R.; Beumont, P.; Birmingham, C.L. Bacterial infections in anorexia nervosa: delayed recognition increases complications. Int. J. Eat. Disord., 2005, 37(3), 261-265.
[http://dx.doi.org/10.1002/eat.20135] [PMID: 15822085]
[36]
Nova, E.; Samartín, S.; Gómez, S.; Morandé, G.; Marcos, A. The adaptive response of the immune system to the particular malnutrition of eating disorders. Eur. J. Clin. Nutr., 2002, 56(S3)(Suppl. 3), S34-S37.
[http://dx.doi.org/10.1038/sj.ejcn.1601482] [PMID: 12142959]
[37]
Tylee, D.S.; Sun, J.; Hess, J.L.; Tahir, M.A.; Sharma, E.; Malik, R.; Worrall, B.B.; Levine, A.J.; Martinson, J.J.; Nejentsev, S.; Speed, D.; Fischer, A.; Mick, E.; Walker, B.R.; Crawford, A.; Grant, S.F.A.; Polychronakos, C.; Bradfield, J.P.; Sleiman, P.M.A.; Hakonarson, H.; Ellinghaus, E.; Elder, J.T.; Tsoi, L.C.; Trembath, R.C.; Barker, J.N.; Franke, A.; Dehghan, A. 23 and Me Research Team. Inflammation Working Group of the CHARGE Consortium; METASTROKE Consortium of the International Stroke Genetics Consortium; Netherlands Twin Registry; neuroCHARGE Working Group; Obsessive Compulsive and Tourette Syndrome Working Group of the Psychiatric Genomics Consortium, Faraone SV, Glatt SJ. Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2018, 177(7), 641-657.
[http://dx.doi.org/10.1002/ajmg.b.32652] [PMID: 30325587]
[38]
Guinhut, M.; Melchior, J.; Godart, N.; Hanachi, M. Extremely severe anorexia nervosa: hospital course of 354 adult patients in a clinical nutrition-eating disorders-unit. Clin. Nutr., 2020, 6, 9-11.
[http://dx.doi.org/10.1016/j.clnu.2020.09.0113] [PMID: 33023762]
[39]
Nilsson, I.A.K.; Millischer, V.; Göteson, A.; Hübel, C.; Thornton, L.M.; Bulik, C.M.; Schalling, M.; Landén, M. Aberrant inflammatory profile in acute but not recovered anorexia nervosa. Brain Behav. Immun., 2020, 88, 718-724.
[http://dx.doi.org/10.1016/j.bbi.2020.05.024] [PMID: 32389698]
[40]
Doig, G.S.; Simpson, F.; Heighes, P.T.; Bellomo, R.; Chesher, D.; Caterson, I.D.; Reade, M.C.; Harrigan, P.W. Refeeding Syndrome 128 Endocrine, Metabolic & Immune Disorders-Drug Targets, 2023, Vol. 23, No. 2 Marucci et al. Trial Investigators Group. Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial. Lancet Respir. Med., 2015, 3(12), 943-952.
[http://dx.doi.org/10.1016/S2213-2600(15)00418-X] [PMID: 26597128]
[41]
Dalton, B.; Bartholdy, S.; Robinson, L.; Solmi, M.; Ibrahim, M.A.A.; Breen, G.; Schmidt, U.; Himmerich, H. A meta-analysis of cytokine concentrations in eating disorders. J. Psychiatr. Res., 2018, 103, 252-264.
[http://dx.doi.org/10.1016/j.jpsychires.2018.06.002] [PMID: 29906710]
[42]
Grifoni, A.; Weiskopf, D.; Ramirez, S.I.; Mateus, J.; Dan, J.M.; Moderbacher, C.R.; Rawlings, S.A.; Sutherland, A.; Premkumar, L.; Jadi, R.S.; Marrama, D.; de Silva, A.M.; Frazier, A.; Carlin, A.F.; Greenbaum, J.A.; Peters, B.; Krammer, F.; Smith, D.M.; Crotty, S.; Sette, A. Targets of T cell responses to sars-cov-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell, 2020, 181(7), 1489-1501.e15.
[http://dx.doi.org/10.1016/j.cell.2020.05.015] [PMID: 32473127]
[43]
Gibson, D.; Mehler, P.S. Anorexia nervosa and the immune system: a narrative review. J. Clin. Med., 2019, 8(11), 1915.
[http://dx.doi.org/10.3390/jcm8111915] [PMID: 31717370]
[44]
Caroleo, M.; Carbone, E.A.; Greco, M.; Corigliano, D.M.; Arcidiacono, B.; Fazia, G.; Rania, M.; Aloi, M.; Gallelli, L.; Segura-Garcia, C.; Foti, D.P.; Brunetti, A. brain-behavior-immune interaction: serum cytokines and growth factors in patients with eating disorders at extremes of the body mass index (BMI) spectrum. Nutrients, 2019, 11(9), 1995.
[http://dx.doi.org/10.3390/nu11091995] [PMID: 31450770]
[45]
Huang, Y.; Lu, Y.; Huang, Y.M.; Wang, M.; Ling, W.; Sui, Y.; Zhao, H.L. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism, 2020, 113154378
[http://dx.doi.org/10.1016/j.metabol.2020.154378] [PMID: 33002478]
[46]
Giagulli, V.A.; Guastamacchia, E.; Magrone, T.; Jirillo, E.; Lisco, G.; De Pergola, G.; Triggiani, V. Worse progression of COVID-19 in men: Is testosterone a key factor? Andrology, 2021, 9(1), 53-64.
[http://dx.doi.org/10.1111/andr.12836] [PMID: 32524732]
[47]
Radzikowska, U.; Ding, M.; Tan, G.; Zhakparov, D.; Peng, Y.; Wawrzyniak, P.; Wang, M.; Li, S.; Morita, H.; Altunbulakli, C.; Reiger, M.; Neumann, A.U.; Lunjani, N.; Traidl-Hoffmann, C.; Nadeau, K.C.; O’Mahony, L.; Akdis, C.; Sokolowska, M. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy, 2020, 75(11), 2829-2845.
[http://dx.doi.org/10.1111/all.14429] [PMID: 32496587]
[48]
Lisco, G.; Giagulli, V.A.; De Pergola, G.; De Tullio, A.; Guastamacchia, E.; Triggiani, V. COVID-19 in man: a very dangerous affair. Endocr. Metab. Immune Disord. Drug Targets, 2021, 21(9), 1544-1554.
[http://dx.doi.org/10.2174/1871530321666210101123801] [PMID: 33388025]
[49]
Mahon, P.B.; Hildebrandt, T.B.; Burdick, K.E. New genetic discoveries in anorexia nervosa: implications for the field. Am. J. Psychiatry, 2017, 174(9), 821-822.
[http://dx.doi.org/10.1176/appi.ajp.2017.17050574] [PMID: 28859512]
[50]
Wells, J.C. Ethnic variability in adiposity and cardiovascular risk: the variable disease selection hypothesis. Int. J. Epidemiol., 2009, 38(1), 63-71.
[http://dx.doi.org/10.1093/ije/dyn183] [PMID: 18820320]
[51]
Bulik, C.M.; Flatt, R.; Abbaspour, A.; Carroll, I. Reconceptualizing anorexia nervosa. Psychiatry Clin. Neurosci., 2019, 73(9), 518-525.
[http://dx.doi.org/10.1111/pcn.12857] [PMID: 31056797]
[52]
Vuillier, L.; May, L.; Greville-Harris, M.; Surman, R.; Moseley, R.L. The impact of the COVID-19 pandemic on individuals with eating disorders: the role of emotion regulation and exploration of online treatment experiences. J. Eat. Disord., 2021, 9(1), 10.
[http://dx.doi.org/10.1186/s40337-020-00362-9] [PMID: 33436064]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy